For the first time in human history the possibility of immortality, or at...
- CD47-targeted therapies: the breast cancer mop?
- Through CRISPR gene editing we can change the nature of our species
- Could groundbreaking gene therapies offer a breakthrough to retinal disease sufferers?
- Could a new gene-editing technology permanently cure Duchenne muscular dystrophy?
- George Washington University to conduct Zika virus trial in Brazil
Opdivo (Nivolumab) for the Treatment of Unresectable or Metastatic Melanoma
Opdivo (nivolumab) is indicated for the treatment of unresectable or metastatic melanoma in patients with a positive BRAF V600 mutation who were previously treated and made progresssion with Yervoy (ipilimumab).
Through CRISPR gene editing we can change the nature of our species
In 2018, we can expect to see large numbers of CRISPR trials taking off all over the world and we should not be afraid of this technology, because we severely need it if we want to cure chronic disease or change our nature to better cope with a changing environment and new challenges for our species.
Duaklir Genuair for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Duaklir Genuair (aclidinium bromide / formoterol fumarate) is an inhalation powder indicated as a maintenance bronchodilator treatment for chronic obstructive pulmonary disease (COPD).
Gazyva (obinutuzumab) for the Treatment of Chronic Lymphocytic Leukaemia (CLL)
Gazyva (obinutuzumab / GA101) is a monoclonal antibody indicated for the treatment of chronic lymphocytic leukaemia (CLL).
Trumenba Vaccine for Prevention of Meningococcal Meningitis B Disease
Trumenba is a vaccine licenced in the US for the prevention of invasive meningococcal meningitis B in adolescents and young adults between ten and 25 years.
Stivarga (Regorafenib) for Treating Metastatic Colorectal Cancer (mCRC)
Stivarga (Regorafenib) is an oral multikinase inhibitor developed by Bayer HealthCare for the treatment of metastatic colorectal cancer (mCRC).
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.